The identification of the LINC01094/miR-184/SLC2A3 axis in the progression of ccRCC may aid with a better understanding of the mechanisms of ccRCC, as well as with potential of serving as a target for ccRCC treatments in the future. This evidence concerns the gene SLC2A3 and nonpapillary renal cell carcinoma.